photo of

Details

Role Team Leader / Dir. Cord Blood Bank
Research area Stem Cell Medicine

Contact

Available for student supervision
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..

Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.

Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord...
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..

Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.

Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.

Top Publications

  • Suraweera, N, Mouradov, D, Li, S, Jorissen, RN, Hampson, D, Ghosh, A, Sengupta, N, Thaha, M, Ahmed, S, Kirwan, M, et al. Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer.. Oncotarget 7(24) : 36474 -36488 2016
    view publication
  • Gilfillan, C, Naidu, P, Gunawan, F, Hassan, F, Tian, P, Elwood, N. Leukocyte Telomere Length in the Neonatal Offspring of Mothers with Gestational and Pre-Gestational Diabetes.. PLoS One 11(10) : e0163824 2016
    view publication
  • Brizard, CP, Looi, JYJ, Smolich, JJ, Horton, SB, Angerosa, J, Elwood, NJ, Pepe, S. Safety of Intracoronary Human Cord Blood Stem Cells in a Lamb Model of Infant Cardiopulmonary Bypass.. Ann Thorac Surg 100(3) : 1021 -1029 2015
    view publication
  • Crompton, KE, Elwood, N, Kirkland, M, Clark, P, Novak, I, Reddihough, D. Feasibility of trialling cord blood stem cell treatments for cerebral palsy in Australia.. J Paediatr Child Health 50(7) : 540 -544 2014
    view publication
  • Morenos, L, Chatterton, Z, Ng, JL, Halemba, MS, Parkinson-Bates, M, Mechinaud, F, Elwood, N, Saffery, R, Wong, NC. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.. Mol Cancer 13: 123 2014
    view publication

Page 8 of 14